Sale

United States Topical Pain Relief Market

United States Topical Pain Relief Market Size, Analysis: By Therapeutic Class: Non-Opioids, Opioids; By Formulation: Cream, Gel, Spray, Patch, Others; By Type: Prescription Pain Relief, Over-The-Counter Pain Relief; By Distribution Channel: Pharmaceutical and Drug Store, E-Commerce, Retail & Grocery Stores; Competitive Landscape; 2024-2032

United States Topical Pain Relief Market Outlook

The value of the United States topical pain relief market in 2023 was estimated at USD 3.30 billion and is expected to achieve USD 6.95 billion by 2032 at a CAGR of 8.6% from 2024 to 2032.

 

United States Topical Pain Relief Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The non-opioid segment of the industry leads the market over the opioid segment. The non-opioid segment is being driven by the easy availability of non-opioid products. Consumers are also increasingly choosing non-opioid products over opioid topical pain relief products, thus, further driving the segment growth. Lesser side effects and the ease of availability of cream-based products is driving the rising demand for cream-based formulations in the industry. E-commerce is emerging as a fast-growing distribution channel for the products, buoyed by the falling data costs and the increasing access to the internet.

 

Market Segmentation

Pain is an irritable feeling, generally caused by extreme or toxic stimuli. Pain connected to severe circumstances is a common symptom. Managing pain includes the use of medicines or antibiotics and treatments to cure multiple sites of pain. These are recognized as topical pain relief whenever these medicines are given straight onto the skin. Such painkillers include anti-inflammatory drugs, anaesthetics, capsaicin, and opioids, which are not steroidal. Most of them are accessible as over the counter (OTC) goods, while some are only accessible by prescription.

 

United States Topical Pain Relief Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The United States topical pain relief industry can be divided on the basis on segments like therapeutic class, formulation, and distribution channel. The industry can be classified on the basis of therapeutic class into non-opioids and opioids. Based on formulation, the industry can be categorised as cream, gel, spray, and patch.

The industry can be broadly categorised, based on its distribution channel segments into:

  • Pharmacies and drug stores
  • E-Commerce
  • Retail and grocery stores

 

Market Analysis

The rising incidences of arthritis, joint pain, and diabetic neuropathy is driving the industry growth. The growing geriatric population in the US is providing further impetus to the industry. Fewer side effects induced by topical pain relief related to oral medicine is driving the industry forward. Greater accessibility and growing awareness of topical pain medications are further aiding the industry growth.

 

United States Topical Pain Relief Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the United States topical pain relief market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • AdvaCare Pharma
  • GlaxoSmithKline Plc
  • Johnson & Johnson Services, Inc.
  • Novartis AG
  • Pfizer Inc.
  • Reckitt Benckiser Group PLC
  • Sanofi 
  • Sun Pharmaceutical Industries Ltd. 
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s five forces.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Therapeutic Class
  • Formulation
  • Type
  • Distribution Channel
Breakup by Therapeutic Class
  • Non-Opioids
  • Opioids
Breakup by Formulation
  • Cream
  • Gel
  • Spray
  • Patch
  • Others
Breakup by Type
  • Prescription Pain Relief
  • Over-The-Counter Pain Relief
Breakup by Distribution Channel
  • Pharmacies and Drug Stores
  • E-Commerce
  • Retail & Grocery Stores
Market Dynamics
  • SWOT Analysis
  • Porter's Five Forces Analysis
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  •  AdvaCare Pharma
  • GlaxoSmithKline Plc.
  • Johnson & Johnson Services, Inc.
  • Pfizer Inc.
  • Reckitt Benckiser Group PLC
  • Novartis AG
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    United States
    6.2    Regional
7    Opportunities and Challenges in the Market
8    United States Topical Pain Relief Market Analysis

    8.1    Key Industry Highlights
    8.2    United States Topical Pain Relief Historical Market (2018-2023) 
    8.3    United States Topical Pain Relief Market Forecast (2024-2032)
    8.4    United States Topical Pain Relief Market by Therapeutic Class
        8.4.1    Non-Opioids
            8.4.1.1    Historical Trend (2018-2023)
            8.4.1.2    Forecast Trend (2024-2032)
        8.4.2    Opioids
            8.4.2.1    Historical Trend (2018-2023)
            8.4.2.2    Forecast Trend (2024-2032)
    8.5    United States Topical Pain Relief Market by Formulation
        8.5.1     Cream 
            8.5.1.1    Historical Trend (2018-2023)
            8.5.1.2    Forecast Trend (2024-2032)
        8.5.2    Gel
            8.5.2.1    Historical Trend (2018-2023)
            8.5.2.2    Forecast Trend (2024-2032)
        8.5.3    Spray
            8.5.3.1    Historical Trend (2018-2023)
            8.5.3.2    Forecast Trend (2024-2032)
        8.5.4    Patch
            8.5.4.1    Historical Trend (2018-2023)
            8.5.4.2    Forecast Trend (2024-2032)
        8.5.5    Others
    8.6    United States Topical Pain Relief Market by Type
        8.6.1     Prescription Pain Relief  
            8.6.1.1    Historical Trend (2018-2023)
            8.6.1.2    Forecast Trend (2024-2032)
        8.6.2    Over-The-Counter Pain Relief
            8.6.2.1    Historical Trend (2018-2023)
            8.6.2.2    Forecast Trend (2024-2032)
    8.7    United States Topical Pain Relief Market by Distribution Channel
        8.7.1     Pharmaceutical and Drug Store 
            8.7.1.1    Historical Trend (2018-2023)
            8.7.1.2    Forecast Trend (2024-2032)
        8.7.2    E-Commerce 
            8.7.2.1    Historical Trend (2018-2023)
            8.7.2.2    Forecast Trend (2024-2032)
        8.7.3    Retail & Grocery Stores
            8.7.3.1    Historical Trend (2018-2023)
            8.7.3.2    Forecast Trend (2024-2032)
9    Market Dynamics
    9.1    SWOT Analysis
        9.1.1    Strengths
        9.1.2    Weaknesses
        9.1.3    Opportunities
        9.1.4    Threats
    9.2    Porter’s Five Forces Analysis
        9.2.1    Supplier’s Power
        9.2.2    Buyer’s Power
        9.2.3    Threat of New Entrants
        9.2.4    Degree of Rivalry
        9.2.5    Threat of Substitutes
    9.3    Key Indicators for Demand
    9.4    Key Indicators for Price
10    Competitive Landscape
    10.1    Market Structure
    10.2    Company Profiles
        10.2.1    AdvaCare Pharma
            10.2.1.1    Company Overview
            10.2.1.2    Product Portfolio
            10.2.1.3    Demographic Reach and Achievements
            10.2.1.4    Certifications
        10.2.2    GlaxoSmithKline Plc.
            10.2.2.1    Company Overview
            10.2.2.2    Product Portfolio
            10.2.2.3    Demographic Reach and Achievements
            10.2.2.4    Certifications
        10.2.3    Johnson & Johnson Services, Inc.
            10.2.3.1    Company Overview
            10.2.3.2    Product Portfolio
            10.2.3.3    Demographic Reach and Achievements
            10.2.3.4    Certifications
        10.2.4    Pfizer Inc.
            10.2.4.1    Company Overview
            10.2.4.2    Product Portfolio
            10.2.4.3    Demographic Reach and Achievements
            10.2.4.4    Certifications
        10.2.5    Reckitt Benckiser Group PLC
            10.2.5.1    Company Overview
            10.2.5.2    Product Portfolio
            10.2.5.3    Demographic Reach and Achievements
            10.2.5.4    Certifications
        10.2.6     Novartis AG
            10.2.6.1    Company Overview
            10.2.6.2    Product Portfolio
            10.2.6.3    Demographic Reach and Achievements
            10.2.6.4    Certifications
        10.2.7     Sanofi
            10.2.7.1    Company Overview
            10.2.7.2    Product Portfolio
            10.2.7.3    Demographic Reach and Achievements
            10.2.7.4    Certifications
        10.2.8     Sun Pharmaceutical Industries Ltd.
            10.2.8.1    Company Overview
            10.2.8.2    Product Portfolio
            10.2.8.3    Demographic Reach and Achievements
            10.2.8.4    Certifications
        10.2.9    Others
11    Key Trends and Developments in the Market


List of Key Figures and Tables

1.    United States Topical Pain Relief Market: Key Industry Highlights, 2018 and 2032
2.    United States Topical Pain Relief Historical Market: Breakup by Therapeutic Class (USD Billion), 2018-2023
3.    United States Topical Pain Relief Market Forecast: Breakup by Therapeutic Class (USD Billion), 2024-2032
4.    United States Topical Pain Relief Historical Market: Breakup by Formulation (USD Billion), 2018-2023
5.    United States Topical Pain Relief Market Forecast: Breakup by Formulation (USD Billion), 2024-2032
6.    United States Topical Pain Relief Historical Market: Breakup by Type (USD Billion), 2018-2023
7.    United States Topical Pain Relief Market Forecast: Breakup by Type (USD Billion), 2024-2032
8.    United States Topical Pain Relief Historical Market: Breakup by Distribution Channel (USD Billion), 2018-2023
9.    United States Topical Pain Relief Market Forecast: Breakup by Distribution Channel (USD Billion), 2024-2032
10.    United States Topical Pain Relief Market Structure

Key Questions Answered in the Report

In 2023, the United States topical pain relief market attained a value of nearly USD 3.30 billion.

The market is projected to grow at a CAGR of 8.6% between 2024 and 2032.

The major drivers of the industry include the  fewer side effects induced by topical pain relief, growing awareness of topical pain medications, easy availability of non-opioid products, and rising demand for cream-based formulations.

The key trends driving the market growth are the rising incidences of arthritis, joint pain, and diabetic neuropathy, and the growing geriatric population.

The non-opioid segment of the industry leads the market over the opioid segment.

Based on formulation, the industry can be categorised as cream, gel, spray, and patch.

The types include prescription pain relief and over-the-counter pain relief.

E-commerce is emerging as a fast-growing distribution channel for the products.

The major players in the industry are AdvaCare Pharma, GlaxoSmithKline plc. (LON: GSK), Johnson & Johnson Services, Inc., Pfizer Inc., Reckitt Benckiser Group PLC, Novartis AG, Sanofi, and Sun Pharmaceutical Industries Ltd., among others.

Analyst Review

The United States topical pain relief market attained a value of USD 3.30 billion in 2023, driven by the growing cases of arthritis, joint pain, and diabetic neuropathy. Aided by the growing awareness of topical pain medications and the growing geriatric population, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 8.6%.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its types, the United States topical pain relief industry can be segmented into prescription pain relief and over-the-counter pain relief. By therapeutic class, the market can be divided into non-opioids and opioids, with non-opioids accounting for the largest market share. Based on formulation the industry can be classified into cream, gel, spray, and patch. On the basis of distribution channels, the market can be segmented into pharmacies and drug stores, e-commerce, retail, and grocery stores. The key players in the above market include AdvaCare Pharma, GlaxoSmithKline plc. , Johnson & Johnson Services, Inc.,  Pfizer Inc. , Reckitt Benckiser Group plc , Novartis AG, Sanofi, and Sun Pharmaceutical Industries Ltd., among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$ 1999     $1699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3999     $3699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 6299     $5699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 8499     $7699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER